The ReadoutA new coronavirus accelerator & whither Intarcia’s FDA decision? By Kate Sheridan March 10, 2020 Reprints Alex Hogan/STAT The Readout for March 10, 2020 About the Author Reprints Kate Sheridan Research Reporter Kate collects and analyzes documents, data, and other information for biotech, health tech, science, and politics stories. @sheridan_kate
The Readout Meghana Keshavan Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
The Readout Damian Garde Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
A STAT Investigation Casey Ross and Bob Herman STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
Special Report Jason Mast, Allison DeAngelis and Megan Molteni STAT Plus: CRISPR patent fight redux? A new battle is brewing among biotechs over next-gen gene-editing tools
